Form 8-K Terns Pharmaceuticals, For: Sep 09
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Terns Pharmaceuticals (TERN) PT Raised to $30 at Jefferies Following +16% Gain Today
September 9, 2024 4:00 PM EDTJefferies analyst Akash Tewari raised the price target on Terns Pharmaceuticals (NASDAQ: TERN) to $30.00 (from $22.00) while maintaining a Buy rating.
The analyst comments "TERN-601 Ph1 readout in-line w/ our bull case: ~5% pbo-adj WL & ~88% nausea/~78% vomiting at the highest 740mg qd dose.... More
